History of surgery for temporal lobe epilepsy

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ali A. Asadi-Pooya, Cyrus Rostami
The history of epilepsy and its treatment goes back to ancient times when it included medicinal herbs, lifestyle modifications, and even surgery. Trepanation is considered the oldest surgical procedure for the treatment of epilepsy. The first series of temporal lobectomies for the treatment of drug-resistant epilepsy were reported by Penfield and ...

Seguir leyendo →
0

Correlates of perceived stigma for people living with epilepsy: A meta-analysis

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ying Shi, Shouqi Wang, Jie Ying, Meiling Zhang, Pengcheng Liu, Huanhuan Zhang, Jiao Sun

Objective
Epilepsy, one of the most common, serious chronic neurological diseases, is accompanied by different levels of perceived stigma that affects people in almost all age groups. This stigma can negatively impact the ...

Seguir leyendo →
0

Correlates of perceived stigma for people living with epilepsy: A meta-analysis

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ying Shi, Shouqi Wang, Jie Ying, Meiling Zhang, Pengcheng Liu, Huanhuan Zhang, Jiao Sun

Objective
Epilepsy, one of the most common, serious chronic neurological diseases, is accompanied by different levels of perceived stigma that affects people in almost all age groups. This stigma can negatively impact the ...

Seguir leyendo →
0

The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ramses Ribot, Bichun Ouyang, Andres M. Kanner

Purpose
Depression and anxiety disorders in patients with epilepsy (PWE) remain under-recognized and under-treated, despite being the most common psychiatric co-morbidities. Selective serotonin re-uptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) are considered first-line treatment for primary depression and anxiety disorders. We performed this study to investigate if ...

Seguir leyendo →
0

The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ramses Ribot, Bichun Ouyang, Andres M. Kanner

Purpose
Depression and anxiety disorders in patients with epilepsy (PWE) remain under-recognized and under-treated, despite being the most common psychiatric co-morbidities. Selective serotonin re-uptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) are considered first-line treatment for primary depression and anxiety disorders. We performed this study to investigate if ...

Seguir leyendo →
0

Surgical outcome in adolescents with mesial temporal sclerosis: Is it different?

Publication date: April 2017Source:Epilepsy & Behavior, Volume 69
Author(s): Pue Farooque, Lawrence Hirsch, Susan Levy, Francine Testa, Richard Mattson, Dennis Spencer
There are extensive studies evaluating mesial temporal sclerosis (MTS) in adults and limited studies in children, with adolescents being included within both patient populations. Our aim was to evaluate predictors of surgical outcome solely in adolescent patients with ...

Seguir leyendo →
0

The effect of lamotrigine on learning in mice using the passive avoidance model

Publication date: April 2017Source:Epilepsy & Behavior, Volume 69
Author(s): Fatemeh Izadpanah, Fatemeh Arab, Amin Zarghami, Ali Bijani, Sohrab Kazemi, Ali Akbar Moghadamnia

Introduction
Lamotrigine (LTG) is an antiepileptic drug that inhibits the release of glutamate by blocking sodium channels. The present study was conducted to evaluate the effect of LTG in different stages of memory using a passive avoidance learning ...

Seguir leyendo →
0

Clinical characteristics, treatments, and outcomes of patients with anti-N-methyl-d-aspartate receptor encephalitis: A systematic review of reported cases

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Le Zhang, Meng-Qian Wu, Zi-Long Hao, Siew Mun Vance Chiang, Kun Shuang, Min-Tao Lin, Xiao-Sa Chi, Jia-Jia Fang, Dong Zhou, Jin-Mei Li
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a recently recognized autoimmune disorder which is responsive to immunotherapy. However, the outcomes of different ...

Seguir leyendo →
0

Clinical characteristics, treatments, and outcomes of patients with anti-N-methyl-d-aspartate receptor encephalitis: A systematic review of reported cases

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Le Zhang, Meng-Qian Wu, Zi-Long Hao, Siew Mun Vance Chiang, Kun Shuang, Min-Tao Lin, Xiao-Sa Chi, Jia-Jia Fang, Dong Zhou, Jin-Mei Li
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a recently recognized autoimmune disorder which is responsive to immunotherapy. However, the outcomes of different ...

Seguir leyendo →
0

Clinical characteristics, treatments, and outcomes of patients with anti-N-methyl-d-aspartate receptor encephalitis: A systematic review of reported cases

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Le Zhang, Meng-Qian Wu, Zi-Long Hao, Siew Mun Vance Chiang, Kun Shuang, Min-Tao Lin, Xiao-Sa Chi, Jia-Jia Fang, Dong Zhou, Jin-Mei Li
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a recently recognized autoimmune disorder which is responsive to immunotherapy. However, the outcomes of different ...

Seguir leyendo →
0
Página 4 de 14 «...23456...»